• Twitter
  • Jobs
ProCURE oncology
  • HOME
  • ABOUT US
  • RESEARCH GROUP
    • Molleví’s Lab
    • Antolin’s Lab
    • Alemany’s & Piulats’s lab
    • Martínez-Balibrea’s Lab
    • Aytes’s Lab
    • Belver’s Lab
    • Pujana’s Lab
    • Menendez’s Lab
    • Sureda’s & Farre’s Lab
    • Casanovas’s Lab
    • Viñals’s lab
  • INNOVATION
  • NEWS
  • CONTACT
  • Menu Menu

News

Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation

19 de March de 2014
Bone Marrow Transplant. 2014 Jun;49(6):744-50. doi: 10.1038/bmt.2014.55.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2014-03-19 10:00:002014-03-19 10:00:00Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation

Linking off-target kinase pharmacology to the differential cellular effects observed among PARP inhibitors

18 de March de 2014
Oncotarget. 2014 May 30;5(10):3023-8. doi: 10.18632/oncotarget.1814.ABSTRACTPARP…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2014-03-18 10:00:002014-03-18 10:00:00Linking off-target kinase pharmacology to the differential cellular effects observed among PARP inhibitors

Tubers from patients with tuberous sclerosis complex are characterized by changes in microtubule biology through ROCK2 signalling

8 de March de 2014
J Pathol. 2014 Jul;233(3):247-57. doi: 10.1002/path.4343. Epub…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2014-03-08 11:00:002014-03-08 11:00:00Tubers from patients with tuberous sclerosis complex are characterized by changes in microtubule biology through ROCK2 signalling

Aberrant gene expression in mucosa adjacent to tumor reveals a molecular crosstalk in colon cancer

7 de March de 2014
Mol Cancer. 2014 Mar 5;13:46. doi: 10.1186/1476-4598-13-46.ABSTRACTBACKGROUND:…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2014-03-07 11:00:002014-03-07 11:00:00Aberrant gene expression in mucosa adjacent to tumor reveals a molecular crosstalk in colon cancer

Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis

5 de March de 2014
J Clin Oncol. 2014 Apr 1;32(10):1031-9. doi: 10.1200/JCO.2013.51.1857.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2014-03-05 11:00:002014-03-05 11:00:00Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis

Integrated genomic and prospective clinical studies show the importance of modular pleiotropy for disease susceptibility, diagnosis and treatment

28 de February de 2014
Genome Med. 2014 Feb 26;6(2):17. doi: 10.1186/gm534. eCollection…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2014-02-28 11:00:002014-02-28 11:00:00Integrated genomic and prospective clinical studies show the importance of modular pleiotropy for disease susceptibility, diagnosis and treatment

Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype

7 de February de 2014
EMBO Mol Med. 2014 Apr;6(4):539-50. doi: 10.1002/emmm.201303214.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2014-02-07 11:00:002014-02-07 11:00:00Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype

Use of the quality management system “JACIE” and outcome after hematopoietic stem cell transplantation

4 de February de 2014
Haematologica. 2014 May;99(5):908-15. doi: 10.3324/haematol.2013.096461.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 2014-02-04 11:00:002014-02-04 11:00:00Use of the quality management system “JACIE” and outcome after hematopoietic stem cell transplantation

Molecular biology of neuroendocrine tumors: from pathways to biomarkers and targets

31 de December de 2013
Cancer Metastasis Rev. 2014 Mar;33(1):345-51. doi: 10.1007/s10555-013-9468-y.ABSTRACTNeuroendocrine…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2013-12-31 11:00:002013-12-31 11:00:00Molecular biology of neuroendocrine tumors: from pathways to biomarkers and targets

Antiangiogenic therapies: going beyond their limits

21 de December de 2013
Cancer Discov. 2014 Jan;4(1):31-41. doi: 10.1158/2159-8290.CD-13-0199.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2013-12-21 11:00:002013-12-21 11:00:00Antiangiogenic therapies: going beyond their limits

Water soluble folate-chitosan nanogels crosslinked by genipin

5 de December de 2013
Carbohydr Polym. 2014 Jan 30;101:113-20. doi: 10.1016/j.carbpol.2013.09.014.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2013-12-05 11:00:002013-12-05 11:00:00Water soluble folate-chitosan nanogels crosslinked by genipin

Integrating gene expression and epidemiological data for the discovery of genetic interactions associated with cancer risk

4 de December de 2013
Carcinogenesis. 2014 Mar;35(3):578-85. doi: 10.1093/carcin/bgt403.…
https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg 0 0 miguel https://procure-oncology.com/wp-content/uploads/2023/10/Procure-icoRecurso-1@2x-100.jpg miguel2013-12-04 11:00:002013-12-04 11:00:00Integrating gene expression and epidemiological data for the discovery of genetic interactions associated with cancer risk
Page 71 of 87«‹6970717273›»

Filter by categories

  • Alemany’s & Piulats’s lab (133)
  • Antolin's lab (36)
  • Aytes's Lab (25)
  • Belver's Lab (25)
  • Casanovas's Lab (77)
  • Martínez-Balibrea's Lab (43)
  • Menendez's Lab (121)
  • Molleví's Lab (35)
  • Pujana's Lab (110)
  • Sin categoría (5)
  • Sureda's & Farre's Lab (312)
  • Viñals's lab (111)

Twitter

Tweets by ProcureICO
Program Against Cancer Therapeutic Resistance

CONTACT US

Campus IDIBELL
(L’Hospitalet del Llobregat)
Hospital Duran i Reynals, Gran Via 199,
L’Hospitalet del Llobregat,
Barcelona 08908
Tel. +34 93 260 7952

Campus IGTP-IJC
(Badalona)
Campus Can Ruti – IGTP – Building Muntanya,
Rd. Can Ruti, Camí de les escoles s/n,
Badalona, Barcelona 08916
Tel. +34 93 554 3069

Campus IDIBGI
(Girona)
Parc Hospitalari Martí i Julià de Salt, Dr. Castany s/n,
Salt, Girona 17190
Tel. +34 872 987 087

© Copyright - Edisenius
  • Privacy Policy
  • Cookie Policy
  • Legal Notice
Scroll to top
Manage cookie consent
To offer the best experiences, we use technologies such as cookies to store and/or access device information. Consent to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Failure to consent, or withdrawal of consent, may adversely affect certain features and functions.
Functional Always active
Storage or technical access is strictly necessary for the legitimate purpose of allowing the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. Storage or technical access that is used exclusively for anonymous statistical purposes. Without a requirement, voluntary compliance by your Internet service provider, or additional records from a third party, information stored or retrieved solely for this purpose cannot be used to identify you.
Marketing
Storage or technical access is necessary to create user profiles to send advertising, or to track the user on a website or several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
See preferences
{title} {title} {title}